DIA LIFT Series Biotech Masterclass: Empowering Biotech Breakthroughs

Investor readiness means having the right strategy, structure, and story to attract funding and build confidence among potential investors. For biotech start-ups, this involves mapping critical operational and financial milestones from early lab discovery through clinical development to commercialization. A compelling pitch should clearly articulate the science, market opportunity, regulatory pathway, and financial plan, demonstrating both innovation and a realistic path to returns.